The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome.


Autoria(s): Mullan, Karen
Data(s)

01/05/2006

Identificador

http://pure.qub.ac.uk/portal/en/publications/the-ppargamma-activator-rosiglitazone-fails-to-lower-plasma-acth-levels-in-patients-with-nelsons-syndrome(3932624f-1993-43fe-b8ed-23891efcf81c).html

http://dx.doi.org/10.1111/j.1365-2265.2006.02501.x

http://www.scopus.com/inward/record.url?scp=33645986967&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Mullan , K 2006 , ' The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome. ' Clinical Endocrinology , vol 64(5) , no. 5 , pp. 519-522 . DOI: 10.1111/j.1365-2265.2006.02501.x

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1310 #Endocrinology
Tipo

article